131 filings
Page 4 of 7
8-K
s2jcxsx2rt cgypqo
31 Mar 23
Disrupting Convention in Women’s Health Through Continuous Innovation March 2023 Corporate Presentation 1
5:03pm
8-K
usigm mda7yh7nouii8y
30 Mar 23
Results of Operations and Financial Condition
8:05am
8-K
g0nakl qif1o
13 Mar 23
Other Events
9:28am
8-K
euq62 qg7
21 Dec 22
Femasys Inc. Announces Commercial Availability of its FemCath Intrauterine Device
4:01pm
8-K
y7do1 tm2
10 Nov 22
Femasys Inc. Announces Financial Results for the Third Quarter Ended Third Quarter and Recent Developments Related to Clinical Programs and Commercial Products
8:35am
8-K
2075mt6 20olbp2
20 Oct 22
Disrupting Convention in Women’s Health Through Continuous Innovation October 2022 Corporate Presentation 1
8:34am
8-K
t87 65eql8vz
12 Oct 22
Femasys Inc. Announces the Appointment of Christine Thomas As Senior Vice President of Regulatory and Clinical Affairs
8:46am
8-K
63ez4k2r1gely0eg kx
6 Oct 22
Femasys Inc. Announces Enrollment Completion for Stage 2 Study of FemBloc for Permanent Birth Control
8:49am
8-K
9uphp ozr25474049
29 Sep 22
Femasys Inc. Announces the Commercial Availability of FemCerv® for Cervical Cancer Screening and Expands Management Team
8:41am
8-K
pnabnfxqtq0qa0c9sqn5
10 Aug 22
Femasys Inc. Announces Financial Results for the Second Quarter Ended Second Quarter and Recent Developments Related to Clinical Programs
4:06pm
8-K
fvl23ea hqg8s
2 Aug 22
Disrupting Convention in Women’s Health Through Continuous Innovation August 2022 Corporate Presentation 1
5:08pm
EFFECT
ryc8ifkii2dgh0du
13 Jul 22
Notice of effectiveness
12:15am
424B3
mlt yaeqlcs
12 Jul 22
Prospectus supplement
9:47pm
424B3
l25o9by
12 Jul 22
Prospectus supplement
4:00pm
S-3
dg8d0
1 Jul 22
Shelf registration
4:55pm
8-K
d5i7s ay490
9 Jun 22
Submission of Matters to a Vote of Security Holders
4:15pm